尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Noonberg Sarah B.. Insider active across 2 companies, notably Marinus Pharmaceuticals, INC.. Aggregated, 6 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €8k. Activity tracked since 16 May 2023. The latest transaction was disclosed on 6 June 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Noonberg Sarah B. is a declarant linked to Metagenomi, Inc. and Marinus Pharmaceuticals, INC., with the listed roles of Chief Medical Officer for the former and Director for the latter. The record shows 6 filings in total, and across the 6 sampled filings, sell transactions total 8005 EUR, with Attribution as the most frequent transaction nature, over the period from 2023-05-17 to 2025-06-09.